Crist Frangakis is a founder and C.E.O. of Achelios Therapeutics. He has over 25 years of pharmaceutical research and development experience and led discovery and development of several cardiovascular and metabolic drugs.
Jim is a pharmaceutical scientist who has developed drug delivery technologies and drug products for 30 years. Jim’s research led to topical products for wound healing.
John joined Achelios in January 2016 as chief medical officer and vice president of clinical operations. He previously led clinical development at Pozen, where he managed clinical activities through phase 3 and was part of the executive leadership team.
Mike Fox has over 30 years of pharmaceutical experience in sales, marketing, and business development in domestic and international markets. Mike Fox was marketing director at two ophthalmic companies and responsible for launching Pharmacia’s Xalatan brand.
Achelios Therapeutics’ primary focus is the development of “New Therapeutic Entities” (NTE) for the treatment of pain and inflammation by topically delivered medications.
